Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
212M
-
Number of holders
-
141
-
Total shares
-
51.2M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$289M
-
Value change
-
-$28.4M
-
Put/Call ratio
-
0.12
-
Number of buys
-
74
-
Number of sells
-
-68
-
Price
-
$5.64
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2015
151 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2015.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.2M shares
of 212M outstanding shares and own 24.16% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (6.82M shares), FMR LLC (4.49M shares), STATE STREET CORP (4.23M shares), BAKER BROS. ADVISORS LP (3.76M shares), BlackRock Fund Advisors (2.66M shares), VANGUARD GROUP INC (2.48M shares), MILLENNIUM MANAGEMENT LLC (2.36M shares), Bank of New York Mellon Corp (1.95M shares), BlackRock Institutional Trust Company, N.A. (1.73M shares), and Voya Investment Management LLC (1.32M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.